Apex Biotechnology (1733.TW) Earnings Analysis

Apex Biotechnology (1733.TW) next reports earnings on 2026-08-12. Last quarter (2026-03-13) it missed with EPS 0.5 TWD vs 1.73 TWD est (-71.1%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 17.39.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1733.TW next report earnings?

Next earnings date2026-08-12
Consensus EPS estimaten/a
Revenue estimaten/a

1733.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-130.5 TWD1.73 TWD-71.1%Miss
2025-11-070.22 TWDn/an/an/a
2025-08-080.29 TWDn/an/an/a
2024-08-090.27 TWD0.06 TWD+350%Beat

Beat rate: 1/2 (50%) over reported quarters with consensus data.

1733.TW valuation and analyst view

Trailing P/E17.39
Trailing EPS1.815 TWD
Price / book1.75
Dividend yield4.11%
Market cap3.16B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Apex Biotechnology (1733.TW)'s next earnings date?

Apex Biotechnology is next scheduled to report on 2026-08-12.

Did 1733.TW beat earnings last quarter?

In its 2026-03-13 report, 1733.TW posted EPS of 0.5 TWD versus a 1.73 TWD estimate — a miss of 71.1%.

What is 1733.TW's earnings track record?

Over the last 2 reported quarters with consensus data, 1733.TW beat estimates 1 times (50%).

What is 1733.TW's current P/E ratio and EPS?

1733.TW trades at a trailing P/E of 17.39 on trailing EPS of 1.815284151427974 TWD.

What do analysts rate 1733.TW?

1733.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.